Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung‐Jue Bang(National University College), Eric Van Cutsem(Universitair Ziekenhuis Leuven), A. Feyereislova(Roche (Switzerland)), Hyun Cheol Chung(Yonsei University), Lin Shen(Peking University), Akira Sawaki(Aichi Cancer Center), Florian Lordick(National Center for Tumor Diseases), Atsushi Ohtsu(National Cancer Center Hospital East), Yasushi Omuro(Tokyo Metropolitan Komagome Hospital), Taroh Satoh(Kindai University), Giuseppe Aprile, Е. С. Куликов(State Healthcare Institution "Regional Clinical Oncological Dispensary"), Julie Hill(Roche (Switzerland)), Michaela Lehle(Roche (Switzerland)), Josef Rüschoff, Yoon‐Koo Kang(Asan Medical Center)
Cited by 7,264Open Access